Enzo Biochem, Inc. (NYSE:ENZ)
CAPS Rating:
The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.
RSS Headlines
Fool UK
Recs
12/18/06 from Red Herring-- Life sciences firm Enzo Biochem, which launched a patent war by claiming that it invented a technique central to DNA sequencing, has raised $43.1 million by selling stock to institutional investors.